XML 49 R29.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Segment Information | 12 Months Ended
--- | ---
Dec. 31, 2016
Segment Reporting [Abstract] |
Segment Information | SEGMENT INFORMATION The company consists of 7 businesses which are aggregated into 6 reportable segments based on similar economic characteristics, the nature of the products and production processes, end-use markets, channels of distribution and regulatory environment. The company's reportable segments are Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials and Protection Solutions. The company includes certain businesses not included in the reportable segments, such as pre-commercial programs, nonaligned businesses and pharmaceuticals in Other. Pre-commercial programs include approximately $420 for the investment in a cellulosic biofuel facility in Nevada, Iowa which includes all material, engineering, and technical design costs involved in construction of the facility. The facility is expected to commence initial production activities in mid-2017. Major products by segment include: Agriculture (corn hybrids and soybean varieties, herbicides, fungicides and insecticides); Electronics & Communications (printing and packaging materials, photopolymers and electronic materials); Industrial Biosciences (enzymes, bio-based materials and process technologies); Nutrition & Health (probiotics, cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients); Performance Materials (engineering polymers, packaging and industrial polymers, films and elastomers); and Protection Solutions (nonwovens, aramids and solid surfaces). The company operates globally in substantially all of its product lines. In general, the accounting policies of the segments are the same as those described in Note 1. Exceptions are noted as follows and are shown in the reconciliations below. Segment net assets includes net working capital, net property, plant and equipment, and other noncurrent operating assets and liabilities of the segment. Depreciation and amortization includes depreciation on research and development facilities and amortization of other intangible assets, excluding write-down of assets. Segment operating earnings is defined as income (loss) from continuing operations before income taxes excluding significant pre-tax benefits (charges), non-operating pension and other post employment benefit (OPEB) costs, exchange gains (losses), corporate expenses and interest. Non-operating pension and OPEB costs includes all of the components of net periodic benefit cost from continuing operations with the exception of the service cost component. DuPont Sustainable Solutions, previously within the company's former Safety & Protection segment (now Protection Solutions) was comprised of two business units: clean technologies and consulting solutions. Effective January 1, 2016, the clean technologies business unit is reported within the Industrial Biosciences segment, and the consulting solutions business unit is reported within Other. Reclassifications of prior year data have been made to conform to current year classifications.
| Agriculture | Electronics & Communications | Industrial Biosciences | Nutrition & Health | Performance Materials | Protection Solutions | Other | Total
2016 |  |  |  |  |  |  |  |
Net sales | $ | 9,516 |  | $ | 1,960 |  | $ | 1,500 |  | $ | 3,268 |  | $ | 5,249 |  | $ | 2,954 |  | $ | 147 |  | $ | 24,594 |
Operating earnings | 1,758 |  | 358 |  | 270 |  | 504 |  | 1,297 |  | 668 |  | (215 | ) | 4,640 |
Depreciation and amortization | 417 |  | 87 |  | 100 |  | 223 |  | 130 |  | 146 |  | 10 |  | 1,113 |
Equity in earnings (losses) of affiliates, net | 7 |  | 31 |  | 12 |  | — |  | 27 |  | 33 |  | (11 | ) | 99 |
Segment net assets | 6,342 |  | 1,186 |  | 2,855 |  | 5,182 |  | 2,711 |  | 2,220 |  | 321 |  | 20,817 |
Affiliate net assets | 222 |  | 146 |  | 39 |  | 4 |  | 146 |  | 81 |  | 11 |  | 649 |
Purchases of property, plant and equipment | 345 |  | 51 |  | 64 |  | 111 |  | 160 |  | 120 |  | 28 |  | 879 |
2015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales | $ | 9,798 |  | $ | 2,070 |  | $ | 1,478 |  | $ | 3,256 |  | $ | 5,305 |  | $ | 3,039 |  | $ | 184 |  | $ | 25,130 |
Operating earnings | 1,646 |  | 359 |  | 243 |  | 373 |  | 1,216 |  | 641 |  | (235 | ) | 4,243 |
Depreciation and amortization | 453 |  | 100 |  | 101 |  | 236 |  | 125 |  | 156 |  | 6 |  | 1,177 |
Equity in earnings (losses) of affiliates, net | 31 |  | 24 |  | 7 |  | — |  | (8 | ) | 23 |  | (30 | ) | 47 |
Segment net assets | 6,751 |  | 1,323 |  | 3,154 |  | 5,457 |  | 2,918 |  | 2,295 |  | 258 |  | 22,156 |
Affiliate net assets | 234 |  | 139 |  | 41 |  | 9 |  | 171 |  | 71 |  | 23 |  | 688 |
Purchases of property, plant and equipment | 334 |  | 45 |  | 84 |  | 120 |  | 159 |  | 96 |  | 132 |  | 970 |
2014 |  |  |  |  |  |  |  |
Net sales | $ | 11,296 |  | $ | 2,381 |  | $ | 1,624 |  | $ | 3,529 |  | $ | 6,059 |  | $ | 3,304 |  | $ | 213 |  | $ | 28,406 |
Operating earnings | 2,352 |  | 336 |  | 269 |  | 369 |  | 1,267 |  | 672 |  | (233 | ) | 5,032 |
Depreciation and amortization | 436 |  | 97 |  | 102 |  | 264 |  | 139 |  | 168 |  | 8 |  | 1,214 |
Equity in earnings (losses) of affiliates, net | 31 |  | 20 |  | 8 |  | — |  | (77 | ) | 28 |  | (47 | ) | (37 | )
Segment net assets | 6,696 |  | 1,359 |  | 3,241 |  | 5,942 |  | 3,125 |  | 2,339 |  | 316 |  | 23,018 |
Affiliate net assets | 240 |  | 137 |  | 45 |  | 7 |  | 238 |  | 78 |  | 16 |  | 761 |
Purchases of property, plant and equipment | 407 |  | 52 |  | 94 |  | 112 |  | 134 |  | 98 |  | 203 |  | 1,100 |
Reconciliation to Consolidated Financial Statements
Segment operating earnings to income from continuing operations before income taxes | 2016 | 2015 | 2014
Total segment operating earnings | $ | 4,640 |  | $ | 4,243 |  | $ | 5,032 |
Significant pre-tax (charges) benefits not included in segment operating earnings | (168 | ) | (38 | ) | 434 |
Non-operating pension and OPEB costs | (40 | ) | (374 | ) | (128 | )
Net exchange (losses) gains | (106 | ) | 30 |  | 196 |
Corporate expenses | (691 | ) | (928 | ) | (844 | )
Interest expense | (370 | ) | (342 | ) | (377 | )
Income from continuing operations before income taxes | $ | 3,265 |  | $ | 2,591 |  | $ | 4,313 |
Segment net assets to total assets at December 31, | 2016 | 2015 | 2014
Total segment net assets | $ | 20,817 |  | $ | 22,156 |  | $ | 23,018 |
Corporate assets 1 | 11,306 |  | 11,163 |  | 12,889 |
Liabilities included in segment net assets | 7,841 |  | 7,847 |  | 8,356 |
Assets related to discontinued operations 2 | — |  | — |  | 6,227 |
Total assets | $ | 39,964 |  | $ | 41,166 |  | $ | 50,490 |
1. | Pension assets are included in corporate assets.
2. | See Note 1 for additional information on the presentation of Performance Chemicals which met the criteria for discontinued operations.
Other items | Segment Totals | Adjustments 1 | Consolidated Totals
2016 |  |  |  |  |  |
Depreciation and amortization | $ | 1,113 |  | $ | 145 |  | $ | 1,258 |
Equity in earnings of affiliates, net | 99 |  | — |  | 99 |
Affiliate net assets | 649 |  | — |  | 649 |
Purchases of property, plant and equipment | 879 |  | 140 |  | 1,019 |
2015 |  |  |  |  |  |
Depreciation and amortization | $ | 1,177 |  | $ | 289 |  | $ | 1,466 |
Equity in earnings of affiliates, net | 47 |  | 2 |  | 49 |
Affiliate net assets | 688 |  | — |  | 688 |
Purchases of property, plant and equipment | 970 |  | 659 |  | 1,629 |
2014 |  |  |  |  |  |
Depreciation and amortization | $ | 1,214 |  | $ | 403 |  | $ | 1,617 |
Equity in (losses) earnings of affiliates, net | (37 | ) | 1 |  | (36 | )
Affiliate net assets | 761 |  | 1 |  | 762 |
Purchases of property, plant and equipment | 1,100 |  | 920 |  | 2,020 |
1. | Adjustments include amounts related to Corporate in all periods presented, and to the Performance Chemicals business in 2015 and 2014, as it met the criteria for discontinued operations during 2015. See Note 1 for additional information on the presentation of discontinued operations and See Note 3 for depreciation, amortization and purchases of property, plant and equipment related to Performance Chemicals for the years ended December 31, 2015 and 2014.
Additional Segment Details 2016 included the following significant pre-tax benefits (charges) which are excluded from segment operating earnings:
Agriculture 1,2,3,4 | $ | (37 | )
Electronics & Communications 2,4 | 4 |
Industrial Biosciences 2,4,5 | (152 | )
Nutrition & Health 2,4 | 9 |
Performance Materials 2,4 | 5 |
Protection Solutions 2,4 | 14 |
Other 2 | (11 | )
| $ | (168 | )
1. | Included $30 of net insurance recoveries recorded in other operating charges for recovery of costs for customer claims related to the use of the Imprelis® herbicide. Included a benefit of $23 in other operating charges for reduction in the accrual for customer claims related to the use of the Imprelis® herbicide.
2. | The company recorded a $(3) net restructuring charge in employee separation / asset related charges, net for the year ended December 31, 2016, associated with the 2016 global cost savings and restructuring program. See Note 4 for additional information.
3. | Includes a $(68) restructuring charge recorded in employee separation / asset related charges, net for the year ended December 31, 2016, related to the decision not to re-start the insecticide manufacturing facility at the La Porte site located in La Porte, Texas. See Note 4 for additional information.
4. | The company recorded a $8 restructuring benefit recorded in employee separation/asset related charges, net, for adjustments to the previously recognized severance costs related to the 2014 restructuring program. See Note 4 for additional information.
5. | The company recorded a $(158) charge in employee separation / asset related charges, net, for the year ended December 31, 2016, related to the write-down of indefinite lived intangible assets. See Note 4 for additional information.
2015 included the following significant pre-tax benefits (charges) which are excluded from segment operating earnings:
Agriculture 1,2,5 | $ | 148 |
Electronics & Communications 1,5 | (78 | )
Industrial Biosciences 1,5 | (61 | )
Nutrition & Health 1,5 | (50 | )
Performance Materials 1,5 | (62 | )
Protection Solutions 1,3,5 | 105 |
Other 1,4,5 | (40 | )
| $ | (38 | )
1. | Included a $10 net restructuring benefit recorded in employee separation/asset related charges, net, associated with the 2014 restructuring program. These adjustments were primarily due to the identification of additional projects in certain segments, offset by lower than estimated individual severance costs and workforce reductions achieved through non-severance programs. See Note 4 for additional information.
2. | Included $182 of net insurance recoveries recorded in other operating charges for recovery of costs for customer claims related to the use of the Imprelis® herbicide. Included a benefit of $130 in other operating charges for reduction in the accrual for customer claims related to the use of the Imprelis® herbicide.
3. | Included a gain of $145, net of legal expenses, recorded in other income, net related to the company's settlement of a legal claim.
4. | Included a $(37) pre-tax impairment charge recorded in employee separation / asset related charges, net for a cost basis investment. See Note 4 for additional information.
5. | Included a $(468) restructuring charge consisting of $(463) recorded in employee separation/asset related charges, net and $(5) recorded in other income, net associated with the 2016 global cost savings and restructuring program. See Note 4 for additional information.
2014 included the following significant pre-tax benefits (charges) which are excluded from segment operating earnings:
Agriculture 1,2,3 | $ | 316 |
Electronics & Communications 1 | (84 | )
Industrial Biosciences 1 | (20 | )
Nutrition & Health 1 | (15 | )
Performance Materials 1,4 | 292 |
Protection Solutions 1 | (45 | )
Other 1 | (10 | )
| $ | 434 |
1. | Included a $(407) restructuring charge associated with the 2014 restructuring program consisting of $(342) recorded in employee separation / asset related charges, net and $(65) recorded in other income, net. See Note 4 for additional information.
2. | Included income of $210 for insurance recoveries, recorded in other operating charges associated with the company's process to fairly resolve claims related to the use of Imprelis® herbicide.
3. | Included a gain of $240 recorded in other income, net associated with the sale of the copper fungicide and land management businesses, both within the Agriculture segment.
4. | Included a gain of $391 recorded in other income, net associated with the sale of Glass Laminating Solutions / Vinyls. See Note 3 for additional information.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration